Based on the SMILES representation N#CC(CCN1CCC(C(N)=O)(N2CCCCC2)CC1)(c1ccccc1)c1ccccc1, the molecule has a drug half life time in humans after IV administration of 8.000 hours.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule has a {half_life_duration__names__noun} of {half_life_duration#} {half_life_duration__units}.
1-(3-cyano-3,3-di(cyclohexa-1,3,5-trien-1-yl)propyl]-4-piperidin-1-ylpiperidine-4-carboxamide